Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands

Candan Kendir1, Marjan van den Akker2,3, Rein Vos4,5

  • 1a Department of Family Medicine , Dokuz Eylul University Faculty of Medicine , Izmir , Turkey.

Insights

Cardiovascular diseases (CVD) affect one in four patients, increasing the risk of other chronic conditions. This study highlights the prevalence and associations of CVD comorbidities in primary care.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiology

Background:

  • Comorbidity significantly increases mortality, reduces quality of life, and escalates healthcare utilization.
  • Cardiovascular diseases (CVD) are leading causes of non-communicable disease deaths globally, often presenting with high comorbidity burdens.
  • Effective evaluation of patients with comorbidities is crucial for healthcare providers, especially in primary care.

Purpose of the Study:

  • To investigate the distribution of cardiovascular diseases (CVDs) and their comorbidities across various sociodemographic groups.
  • To identify and analyze the associations between different CVDs and co-occurring comorbidities.

Main Methods:

  • A large-scale, cross-sectional study involving 67,786 patients.
  • Data were sourced from the Registration Network Family Practices (RegistratieNet Huisartspraktijken, RNH).
  • Statistical analyses included chi-square tests and logistic regression to examine comorbidity patterns.

Main Results:

  • 26.5% of patients had at least one CVD diagnosis; 10.5% had two or more.
  • Strongest CVD-CVD association: heart failure and arrhythmias (OR: 9.20).
  • Significant associations found between coronary artery disease/hypertension and diabetes/lipid metabolism disorders; cerebrovascular diseases showed strong links with epilepsy and arrhythmias.

Conclusions:

  • Approximately one in four patients experiences at least one cardiovascular disease.
  • The presence of one CVD elevates the risk of developing additional, co-occurring CVDs.
  • Comorbidity with CVD is associated with a higher burden of other chronic diseases.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
591
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
738
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
434
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
711
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
619